Frontlight ResearchEarly access
Trial site
Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
- 14running trials
- 2closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Childhood cancers2 trials
- Glioblastoma2 trials
- Myeloproliferative neoplasms2 trials
- Chronic spontaneous urticaria1 trial
- Crohn's disease1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Type 2 diabetes1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 37 trials
- Phase 25 trials
- Phase 11 trial
- Status
- Active, not recruiting7 trials
- Recruiting5 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Incyte Corporation3 trials
- University of Birmingham3 trials
- Royal Marsden NHS Foundation Trust2 trials
- Takeda2 trials
- BioNTech SE1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Enrolling by invitation
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients
Active, not recruiting
Active, not recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Active, not recruiting
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Chronic spontaneous urticaria1 recruiting
- Crohn's disease1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026